Variant report
Variant | esv3521454 |
---|---|
Chromosome Location | chr11:74023704-74028502 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:23)
- CpG islands (count:61)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:23 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CBX3 | chr11:74027858-74028188 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr11:74023398-74023778 | HepG2 | liver: | n/a | chr11:74023581-74023592 |
3 | CEBPB | chr11:74023396-74023801 | A549 | lung: | n/a | chr11:74023581-74023592 |
4 | CEBPB | chr11:74023406-74023802 | IMR90 | lung: | n/a | chr11:74023581-74023592 |
5 | CEBPB | chr11:74023429-74023756 | HepG2 | liver: | n/a | chr11:74023581-74023592 |
6 | CEBPB | chr11:74023456-74023744 | H1-hESC | embryonic stem cell: | n/a | chr11:74023581-74023592 |
7 | CEBPB | chr11:74023438-74023800 | MCF-7 | breast: | n/a | chr11:74023581-74023592 |
8 | CEBPB | chr11:74023423-74023752 | K562 | blood: | n/a | chr11:74023581-74023592 |
9 | CEBPB | chr11:74023395-74023856 | A549 | lung: | n/a | chr11:74023816-74023829 chr11:74023581-74023592 |
10 | CEBPB | chr11:74023394-74023814 | Hela-S3 | cervix: | n/a | chr11:74023581-74023592 |
11 | CEBPB | chr11:74023386-74023824 | A549 | lung: | n/a | chr11:74023581-74023592 |
12 | E2F4 | chr11:74028188-74028348 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | EP300 | chr11:74023527-74023727 | Hela-S3 | cervix: | n/a | n/a |
14 | FOXA1 | chr11:74023384-74023784 | HepG2 | liver: | n/a | chr11:74023534-74023549 |
15 | FOXA2 | chr11:74023306-74023762 | A549 | lung: | n/a | n/a |
16 | FOXA2 | chr11:74023426-74023763 | A549 | lung: | n/a | n/a |
17 | GATA3 | chr11:74027870-74028540 | SK-N-SH | brain: | n/a | n/a |
18 | KAP1 | chr11:74027796-74028173 | K562 | blood: | n/a | n/a |
19 | POLR2A | chr11:74026494-74026519 | GM12878 | blood: | n/a | n/a |
20 | POLR2A | chr11:74026301-74026378 | GM12878 | blood: | n/a | n/a |
21 | SETDB1 | chr11:74027797-74028492 | U2OS | brain: | n/a | n/a |
22 | STAT3 | chr11:74023466-74023751 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | ZNF143 | chr11:74027970-74028060 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:74026371-74026421 | LNCaP | prostate: | n/a |
2 | chr11:74026371-74026421 | PANC-1 | pancreas: | n/a |
3 | chr11:74026371-74026421 | SKMC | muscle: | n/a |
4 | chr11:74026371-74026421 | AG10803 | skin: | n/a |
5 | chr11:74026371-74026421 | NHBE | bronchial: | n/a |
6 | chr11:74026371-74026421 | Hela-S3 | cervix: | n/a |
7 | chr11:74026371-74026421 | NHDF-neo | bronchial: | n/a |
8 | chr11:74026371-74026421 | U87 | brain: | n/a |
9 | chr11:74026371-74026421 | CMK | blood: | n/a |
10 | chr11:74026371-74026421 | ProgFib | skin: | n/a |
11 | chr11:74026371-74026421 | HIPEpiC | eye: | n/a |
12 | chr11:74026371-74026421 | SK-N-MC | brain: | n/a |
13 | chr11:74026371-74026421 | AG09319 | gingival: | n/a |
14 | chr11:74026371-74026421 | Hepatocyte | liver: | n/a |
15 | chr11:74026371-74026421 | AG04450 | lung: | fetal |
16 | chr11:74026371-74026421 | PrEC | prostate: | n/a |
17 | chr11:74026371-74026421 | GM12892 | blood: | n/a |
18 | chr11:74026371-74026421 | HepG2 | liver: | n/a |
19 | chr11:74026371-74026421 | T-47D | breast: | n/a |
20 | chr11:74026371-74026421 | K562 | blood: | n/a |
21 | chr11:74026371-74026421 | HEK293 | kidney: | embryo |
22 | chr11:74026371-74026421 | NT2-D1 | testis: | n/a |
23 | chr11:74026371-74026421 | HAEpiC | amniotic membrane: | n/a |
24 | chr11:74026371-74026421 | GM12891 | blood: | n/a |
25 | chr11:74026371-74026421 | ECC-1 | luminal epithelium: | n/a |
26 | chr11:74026371-74026421 | HCT-116 | colon: | n/a |
27 | chr11:74026371-74026421 | HUVEC | blood vessel: | n/a |
28 | chr11:74026371-74026421 | HRCEpiC | kidney: | n/a |
29 | chr11:74026371-74026421 | HCF | heart: | n/a |
30 | chr11:74026371-74026421 | AG09309 | skin: | n/a |
31 | chr11:74026371-74026421 | NH-A | brain: | n/a |
32 | chr11:74026371-74026421 | MCF10A-Er-Src | breast: | n/a |
33 | chr11:74026371-74026421 | HNPCEpiC | eye: | n/a |
34 | chr11:74026371-74026421 | AoSMC | blood vessel: | n/a |
35 | chr11:74026371-74026421 | HL-60 | blood: | n/a |
36 | chr11:74026371-74026421 | SK-N-SH_RA | brain: | n/a |
37 | chr11:74026371-74026421 | PFSK-1 | brain: | n/a |
38 | chr11:74026371-74026421 | ovcar-3 | ovarian: | n/a |
39 | chr11:74026371-74026421 | HRE | kidney: | n/a |
40 | chr11:74026371-74026421 | HCPEpiC | choroid plexus: | n/a |
41 | chr11:74026371-74026421 | SK-N-SH | brain: | n/a |
42 | chr11:74026371-74026421 | BJ | skin: | n/a |
43 | chr11:74026371-74026421 | NB4 | blood: | n/a |
44 | chr11:74026371-74026421 | HCM | heart: | n/a |
45 | chr11:74026371-74026421 | Jurkat | blood: | n/a |
46 | chr11:74026371-74026421 | SAEC | small airway: | n/a |
47 | chr11:74026371-74026421 | HMEC | breast: | n/a |
48 | chr11:74026371-74026421 | Caco-2 | colon: | n/a |
49 | chr11:74026371-74026421 | MCF-7 | breast: | n/a |
50 | chr11:74026371-74026421 | GM06990 | blood: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:74020783..74024598-chr11:74028105..74031169,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
P4HA3 | TF binding region |
P4HA3 | CpG island |
ENSG00000246211 | chromatin interactions |
ENSG00000149380 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7947911 | chr11:74023751-74023752 | Bivalent Enhancer Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs534333812 | chr11:74023778-74023779 | Bivalent Enhancer Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs558022928 | chr11:74023857-74023858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577907133 | chr11:74023860-74023861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536829890 | chr11:74023866-74023867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556774104 | chr11:74023871-74023872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556474930 | chr11:74023895-74023896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577605962 | chr11:74023907-74023908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs184484826 | chr11:74023967-74023968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376336283 | chr11:74023977-74023978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs78724004 | chr11:74023994-74023995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559601574 | chr11:74024003-74024004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553885717 | chr11:74024012-74024013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573181009 | chr11:74024014-74024015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545116727 | chr11:74024015-74024016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs189142438 | chr11:74024110-74024111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531141082 | chr11:74024116-74024117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551310077 | chr11:74024130-74024131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143972874 | chr11:74024135-74024136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs74816809 | chr11:74024181-74024182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572078458 | chr11:74024203-74024204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549062061 | chr11:74024232-74024233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs752577 | chr11:74024240-74024241 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs670974 | chr11:74024257-74024258 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs371787851 | chr11:74024284-74024285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181184824 | chr11:74024286-74024287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186366897 | chr11:74024302-74024303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539369898 | chr11:74024341-74024342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs116638505 | chr11:74024350-74024351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573460032 | chr11:74024399-74024400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34641911 | chr11:74024406-74024407 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536081605 | chr11:74024441-74024442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs553429234 | chr11:74024442-74024443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs4641511 | chr11:74024443-74024444 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs545369097 | chr11:74024464-74024465 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs189300151 | chr11:74024504-74024505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575728546 | chr11:74024520-74024521 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148832670 | chr11:74024524-74024525 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs373150207 | chr11:74024527-74024528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201013537 | chr11:74024535-74024536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs201985261 | chr11:74024536-74024537 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs200386764 | chr11:74024538-74024539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530309818 | chr11:74024574-74024575 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs520523 | chr11:74024586-74024587 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs559377480 | chr11:74024590-74024591 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544505953 | chr11:74024600-74024601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs371795091 | chr11:74024617-74024618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs180827636 | chr11:74024631-74024632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150653778 | chr11:74024683-74024684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs139768812 | chr11:74024697-74024698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 21364760 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:74023000-74023800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
2 | chr11:74023000-74028600 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
3 | chr11:74023200-74023800 | Bivalent Enhancer | HUES6 Cell Line | embryonic stem cell |
4 | chr11:74023200-74023800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr11:74023200-74023800 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr11:74023200-74023800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
7 | chr11:74023200-74027600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr11:74023200-74036800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr11:74023400-74028600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
10 | chr11:74023600-74027800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr11:74024400-74024600 | Enhancers | Primary T cells from cord blood | blood |
12 | chr11:74027400-74027600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
13 | chr11:74027600-74027800 | ZNF genes & repeats | Muscle Satellite Cultured Cells | -- |
14 | chr11:74027600-74028200 | ZNF genes & repeats | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr11:74027800-74028200 | ZNF genes & repeats | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr11:74027800-74028200 | ZNF genes & repeats | NHDF-Ad | bronchial |
17 | chr11:74027800-74029400 | Enhancers | Muscle Satellite Cultured Cells | -- |
18 | chr11:74028000-74031000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
19 | chr11:74028200-74028400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
20 | chr11:74028200-74028400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
21 | chr11:74028200-74028600 | Weak transcription | NHDF-Ad | bronchial |
22 | chr11:74028200-74029600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
23 | chr11:74028400-74030400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
24 | chr11:74028400-74030800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
25 | chr11:74028400-74031000 | Enhancers | Osteobl | bone |